Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
Status:
Unknown status
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of weekly administered combination of docetaxel/cisplatin
and docetaxel/oxaliplatin in chemotherapy-naïve patients with advanced gastric cancer. The
primary endpoint will be the response rate.